Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:30
|
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [31] Coronary artery, cerebrovascular and peripheral vascular disease
    Pedagogos, Eugenie
    NEPHROLOGY, 2010, 15 : S19 - S23
  • [32] Impact of Stable Coronary Artery Disease on the Efficacy of Cryoballoon Ablation for the Atrial Fibrillation
    Liu, Lu
    Zhao, Dongdong
    Zhang, Jun
    Yang, Haotian
    Abdu, Fuad A.
    Guo, Rong
    Li, Shuang
    Tang, Kai
    Li, Hailing
    Che, Wenliang
    Xu, Yawei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (03): : 204 - 211
  • [33] Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation
    Pastori, Daniele
    Pignatelli, Pasquale
    Sciacqua, Angela
    Perticone, Maria
    Violi, Francesco
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 255 : 69 - 73
  • [34] β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
    Bangalore, Sripal
    Steg, Ph Gabriel
    Deedwania, Prakash
    Crowley, Kevin
    Eagle, Kim A.
    Goto, Shinya
    Ohman, E. Magnus
    Cannon, Christopher P.
    Smith, Sidney C., Jr.
    Zeymer, Uwe
    Hoffman, Elaine B.
    Messerli, Franz H.
    Bhatt, Deepak L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (13): : 1340 - 1349
  • [35] Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study
    Dogan, Volkan
    Basaran, Ozcan
    Beton, Osman
    Tekinalp, Mehmet
    Bolat, Ismail
    Kalaycioglu, Ezgi
    Aykan, Ahmet Cagri
    Tasar, Onur
    Safak, Ozgen
    Kalcik, Macit
    Yaman, Mehmet
    Kirma, Cevat
    Biteker, Murat
    CORONARY ARTERY DISEASE, 2016, 27 (06) : 497 - 503
  • [36] Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry
    Fauchier, L.
    Greenlaw, N.
    Ferrari, R.
    Ford, I.
    Fox, K.
    Tardif, J. C.
    Tendera, M.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 97 - 97
  • [37] Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study (vol 125, pg 162, 2015)
    Zielonka, A.
    Tkaczyszyn, M.
    Mende, M.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (04): : 308 - 308
  • [38] Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlap
    Lamblin, Nicolas
    Ninni, Sandro
    Tricot, Olivier
    Meurice, Thibaud
    Lemesle, Gilles
    Bauters, Christophe
    OPEN HEART, 2020, 7 (01):
  • [39] Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease
    Kaikita, Koichi
    Yasuda, Satoshi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (11) : E010476
  • [40] The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy
    Reiffel, James A.
    AMERICAN HEART JOURNAL, 2022, 248 : 163 - 164